These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 16447104

  • 1. Amphotericin B colloidal dispersion for the treatment of Indian visceral leishmaniasis.
    Sundar S, Mehta H, Chhabra A, Singh V, Chauhan V, Desjeux P, Rai M.
    Clin Infect Dis; 2006 Mar 01; 42(5):608-13. PubMed ID: 16447104
    [Abstract] [Full Text] [Related]

  • 2. Safety of a pre-formulated amphotericin B lipid emulsion for the treatment of Indian Kala-azar.
    Sundar S, Chakravarty J, Agarwal D, Shah A, Agrawal N, Rai M.
    Trop Med Int Health; 2008 Sep 01; 13(9):1208-12. PubMed ID: 18664241
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries.
    Berman JD, Badaro R, Thakur CP, Wasunna KM, Behbehani K, Davidson R, Kuzoe F, Pang L, Weerasuriya K, Bryceson AD.
    Bull World Health Organ; 1998 Sep 01; 76(1):25-32. PubMed ID: 9615494
    [Abstract] [Full Text] [Related]

  • 4. Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations.
    Sundar S, Mehta H, Suresh AV, Singh SP, Rai M, Murray HW.
    Clin Infect Dis; 2004 Feb 01; 38(3):377-83. PubMed ID: 14727208
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of high-dose infusions of a preformed amphotericin B fat emulsion for treatment of Indian visceral leishmaniasis.
    Sundar S, Singh A, Agarwal D, Rai M, Agrawal N, Chakravarty J.
    Am J Trop Med Hyg; 2009 May 01; 80(5):700-3. PubMed ID: 19407109
    [Abstract] [Full Text] [Related]

  • 13. Amphotericin B therapy in children with visceral leishmaniasis: daily vs. alternate day, a randomized trial.
    Singh UK, Prasad R, Jaiswal BP, Singh PK, Thakur CP.
    J Trop Pediatr; 2010 Oct 01; 56(5):321-4. PubMed ID: 20065047
    [Abstract] [Full Text] [Related]

  • 14. Oral miltefosine for Indian visceral leishmaniasis.
    Sundar S, Jha TK, Thakur CP, Engel J, Sindermann H, Fischer C, Junge K, Bryceson A, Berman J.
    N Engl J Med; 2002 Nov 28; 347(22):1739-46. PubMed ID: 12456849
    [Abstract] [Full Text] [Related]

  • 15. Amphotericin B lipid complex in the management of antimony unresponsive Indian visceral leishmaniasis.
    Sundar S, Goyal AK, Mandal AK, Makharia MK, Singh VP, Murray HW.
    J Assoc Physicians India; 1999 Feb 28; 47(2):186-8. PubMed ID: 10999086
    [Abstract] [Full Text] [Related]

  • 16. Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial.
    Sundar S, Sinha PK, Rai M, Verma DK, Nawin K, Alam S, Chakravarty J, Vaillant M, Verma N, Pandey K, Kumari P, Lal CS, Arora R, Sharma B, Ellis S, Strub-Wourgaft N, Balasegaram M, Olliaro P, Das P, Modabber F.
    Lancet; 2011 Feb 05; 377(9764):477-86. PubMed ID: 21255828
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.